Pharmamarketeer
wet- en regelgeving

Edwards Lifesciences receives US FDA approval for SAPIEN 3 Ultra transcatheter heart valve

2 januari 2019
Pharma Biz

Edwards Lifesciences Corporation, the global leader in patient─focused innovations for structural heart disease and critical care monitoring, announced that the SAPIEN 3 Ultra system has received US Food and Drug Administration (FDA)

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)